Public Health

GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.

New 14-country study from Ipsos reveals self-blame, outdated narratives and a hidden daily toll.

New global syndicated survey highlights a striking contradiction at the heart of how obesity is understood, especially by those living with it.

Ipsos' Market Essentials infographics offer insights on how consumers think, feel, and engage in activities such as shopping, travel, entertainment, socialization, technology and AI, and work in our dynamic, ever-changing world.

Turn longevity from trend to strategy: where should pharma play - and how to win?

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Across 30 countries, 43% rate the quality of the healthcare they receive as good. For a third year running, mental health is seen as the biggest health issue, with 45% expressing concern. This is up from 27% in 2018. according to the Ipsos Healthcare Services Report 2025.